你即將離開本站

並前往https://www.clinicaltrialsarena.com/news/boehringer-ingelheim-announces-nintedanib-trial-met-its-primary-endpoint/

Boehringer Ingelheim announces nintedanib trial met its ...

Boehringer Ingelheim has presented the data that shows the Phase III INBUILD trial of nintedanib met the primary endpoint.

確定！ 回上一頁

查詢 「INBUILD trial」的人也找了：

  1. INBUILD trial
    2.
  2. SENSCIS trial
    3.
  3. Nintedanib clinical trial
    4.
  4. pf-ild definition
    5.
  5. Pirfenidone
    6.
  6. TOMORROW trial
    7.
  7. RELIEF pirfenidone
    8.
  8. Progressive fibrosing interstitial lung disease
    9.